NT5E and neoplasm: Analysis of RFS and OS in the treatment-naïve and chemotherapy cohorts according to marker levels, dichotomized around the median, showed that the percentage tumor epithelium in a sample was a negative biomarker and that the percentage of CD73-positive tissue in the TME was a prognostic biomarker for both RFS and OS in both cohorts.